CN112441942B - Debromination method of sartan intermediate polybrominated substituent - Google Patents

Debromination method of sartan intermediate polybrominated substituent Download PDF

Info

Publication number
CN112441942B
CN112441942B CN202011554293.XA CN202011554293A CN112441942B CN 112441942 B CN112441942 B CN 112441942B CN 202011554293 A CN202011554293 A CN 202011554293A CN 112441942 B CN112441942 B CN 112441942B
Authority
CN
China
Prior art keywords
polybrominated
substituent
sartan
debromination
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202011554293.XA
Other languages
Chinese (zh)
Other versions
CN112441942A (en
Inventor
张凯伦
曹恩清
王莉
印辉
张丰华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Xinrui Pharmaceutical Co ltd
Original Assignee
Jiangsu Xinrui Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Xinrui Pharmaceutical Co ltd filed Critical Jiangsu Xinrui Pharmaceutical Co ltd
Priority to CN202011554293.XA priority Critical patent/CN112441942B/en
Publication of CN112441942A publication Critical patent/CN112441942A/en
Application granted granted Critical
Publication of CN112441942B publication Critical patent/CN112441942B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/32Separation; Purification; Stabilisation; Use of additives
    • C07C253/34Separation; Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a debromination method of a sartan polybrominated intermediate, which comprises the following steps: taking a brominated crystal mother liquor of a sartan intermediate containing a polybrominated substituent as a raw material, mixing the raw material with diethyl phosphite and alkali, wherein the alkali is selected from any one or more than two mixtures of potassium carbonate or sodium carbonate; the reaction mole ratio of the polybrominated substituent in the raw materials to the alkali is 1:1-3; the reaction molar ratio of the polybrominated substituent in the raw materials to the diethyl phosphite serving as the reducing agent is 1:1-3; reflux reaction in organic solvent for 8-16 hr, water washing, drying, desolventizing and crystallizing to obtain high purity monobromo substituent. The method of the invention achieves the ideal debromination effect of the polybrominated substituent. The monobromo substituent after debromination can be recycled, and the utilization rate of the sartan intermediate is obviously improved.

Description

Debromination method of sartan intermediate polybrominated substituent
Technical Field
The invention belongs to the technical field of medical intermediates, and particularly relates to a debromination method of a sartan intermediate polybrominated substituent.
Background
The intermediate of the bromosartan is a series of common medical intermediates. The intermediate of the bromosartan used in the process of synthesizing the sartan is usually obtained by brominating the intermediate of the bromosartan. The byproduct polybrominated substances are generated in the bromination process, so that the purity of the product is reduced, and the production benefit is reduced.
Therefore, it is necessary to provide a debromination method of a sartan polybrominated intermediate to improve the purity and the production benefit of the product.
Disclosure of Invention
Aiming at the problems related to the background technology, the invention provides a debromination method of a polybrominated substituent of a sartan intermediate, so that the polybrominated substituent of the sartan intermediate can be reused, and the utilization rate of the sartan intermediate can be obviously improved.
In order to solve the technical problems, the invention adopts the following technical scheme:
a process for debrominating a sartan polybrominated intermediate comprising: the preparation method comprises the steps of taking a brominated crystallization mother liquor of a sartan intermediate containing a polybrominated substituent as a raw material, mixing the raw material with diethyl phosphite and alkali, carrying out reflux reaction in an organic solvent for 8-16 hours, and washing, drying, desolventizing and crystallizing the reacted product to obtain the high-purity monobrominated substituent.
In order to further improve the debromination efficiency of the polybrominated substituent, a preferred embodiment of the present invention further comprises spin-drying and desolventizing the raw material to obtain a solid mixture containing the polybrominated substituent.
In the scheme of the invention, the alkali is taken as an acid binding agent to participate in the reaction, and can be selected from any one or more than two mixtures of potassium carbonate or sodium carbonate; preferably potassium carbonate.
In the scheme of the invention, the reaction molar ratio of the polybrominated substituent in the raw materials to the alkali is 1:1-3; preferably 1:1.5-3; most preferably 1:3.
In the scheme of the invention, the diethyl phosphite is taken as a reducing agent to participate in the reaction, and the reaction mole ratio of the polybrominated substituent in the raw material to the diethyl phosphite serving as the reducing agent is 1:1-3; preferably 1:1.5-3; most preferably 1:1.5.
In the scheme of the invention, the reaction temperature is 35-80 ℃, and the reaction time is preferably 16 hours.
In the scheme of the invention, the organic solvent can be esters, hydrocarbons, ethers or alcohols; preferably hydrocarbons; further preferred is dichloromethane or dichloroethane.
In a preferred embodiment of the invention, a brominated crystal mother liquor of a sartan intermediate containing a polybrominated substituent is taken as a raw material, the raw material is spin-dried and desolventized to obtain a solid mixture containing the polybrominated substituent, the solid mixture is mixed with diethyl phosphite and potassium carbonate, so that the molar ratio of the polybrominated substituent to the potassium carbonate in the solid mixture is 1:1.5-3, and the molar ratio of the polybrominated substituent to the diethyl phosphite is 1:1.5-3; after mixing, the mixture is reacted in a hydrocarbon solvent for 16 hours under reflux, and the product after the reaction is washed, dried, desolventized and crystallized to obtain the high-purity monobromo substituent.
Compared with the prior art, the method of the invention furthest promotes the reaction by adding the alkali with proper types and proper proportions as the acid-binding agent in the reaction process. Experiments prove that the inventor can properly increase the use amount of the alkali to ensure that the polybrominated substituent can obtain an ideal debromination effect, but the debromination effect is poor when the use amount of the alkali is too large (the molar ratio of the alkali to the polybrominated substituent exceeds 1:3); furthermore, a particular class of base has desirable effects on the debromination reaction of the invention. In a word, the monobromo substituent obtained by debrominating through the method can be recycled, and the utilization rate of the sartan intermediate is obviously improved.
Detailed Description
The following is a further description of the solution of the invention by way of examples. The solution of the invention is not limited to the examples listed.
Example 1
The synthesis process of the 2-cyano-4' -bromomethyl biphenyl is shown in the following formula (I):
during production of b, byproduct c is produced. During purification of b, the byproduct c is present in the crystallization mother liquor in a large amount.
According to the present invention, there is provided a method for debrominating a polybrominated by-product c contained in the above-mentioned crystallization mother liquor, comprising:
taking 100ml of the crystallization mother liquor as a raw material, spin-drying and desolventizing by a rotary evaporator to obtain 36g of yellow solid, wherein the purity of the yellow solid is a:5%, b:60.24%, c:28.62%. The solid was added with 200ml of methylene chloride to a 500ml flask, followed by addition of 12.2g of potassium carbonate (88.3 mmol) and 6.09g of diethyl phosphite (44.15 mmol), heating to reflux and reaction at a constant temperature for 16 hours. Samples were analyzed for purity by HPLC: a:8%, b:81%, c:5.1%. 100ml×2 water was added to wash twice. 10g of anhydrous magnesium sulfate was added to the mixture to dry the mixture, the mixture was filtered, and the filtrate was cooled to-5℃with stirring. Crystallizing for 2 hours. Filtering, washing the filter cake with 10ml of dichloromethane for 1 time, pumping and drying to obtain the product. The reaction process is shown in the following formula (II):
comparative example 1
100ml of the mother liquor described in example 1 was taken and spin-dried with a rotary evaporator to give 36g of yellow solid with purity a:5%, b:60.24%, c:28.62%. The solid was added with 200ml of dichloromethane to a 500ml vial, 6.98g of ammonium bicarbonate (88.3 mmol) and 6.09g of diethyl phosphite (44.15 mmol) were added continuously, the temperature was raised to reflux, the reaction was kept at rest for 16 hours, and samples were taken for HPLC analysis: a:41.6%, b:2.1%, c:40.09%, and the result shows that the product is destroyed and has no debromination effect.
Comparative example 2
100ml of the mother liquor described in example 1 was taken and spin-dried with a rotary evaporator to give 36g of yellow solid with purity a:5%, b:60.24%, c:28.62%. The solid was added with 200ml of dichloromethane to a 500ml vial, 18.3g of potassium carbonate (132.5 mmol) and 6.09g of diethyl phosphite (44.15 mmol) were added successively, the temperature was raised to reflux, the reaction was kept at rest for 16 hours, and samples were taken for HPLC analysis: a:31%, b:59.0%, c:2.5%.
Comparative example 3
100ml of the mother liquor described in example 1 was taken and spin-dried with a rotary evaporator to give 36g of yellow solid with purity a:5%, b:60.24%, c:28.62%. The solid was added with 200ml of dichloromethane to a 500ml vial, followed by 24.4g of potassium carbonate (176.6 mmol) and 6.09g of diethyl phosphite (44.15 mmol), warmed to reflux, incubated for 16 hours, and sampled for HPLC analysis: a:31.0%, b:61.88%, c:1.68%.
Comparative example 4
100ml of the mother liquor described in example 1 was taken and spin-dried with a rotary evaporator to give 36g of yellow solid with purity a:5%, b:60.24%, c:28.62%. The solid was added with 200ml of dichloromethane to a 500ml vial, 18.7g of sodium carbonate (176.6 mmol) and 6.09g of diethyl phosphite (44.15 mmol) were added successively, the temperature was raised to reflux, the reaction was kept for 16 hours, and samples were taken for HPLC analysis: a:30.0%, b:56.88%, c:5.21%.
Comparative example 5
100ml of the mother liquor described in example 1 was taken and spin-dried with a rotary evaporator to give 36g of yellow solid with purity a:5%, b:60.24%, c:28.62%. The solid was added with 200ml of dichloromethane to a 500ml vial, 18.7g of sodium carbonate (176.6 mmol) and 11.09g of diethyl phosphite (80.3 mmol) were added successively, the mixture was warmed to reflux, the reaction was kept for 16 hours, and samples were taken for HPLC analysis: a:28%, b:65.2%, c:0.56%.
The above embodiments are only for illustrating the technical solution of the present invention and not for limiting the conception and the protection scope of the present invention, and the technical solution of the present invention is modified or equivalent by those of ordinary skill in the art without departing from the spirit and scope of the technical solution, which should be covered in the scope of the claims of the present invention.

Claims (1)

1. A debromination method of a sartan polybrominated intermediate is characterized in that a brominated crystallization mother liquor of the sartan intermediate containing polybrominated substituents, which is generated in the synthesis process of 2-cyano-4' -bromomethyl biphenyl shown in the following formula (I), is taken as a raw material,
the debromination method specifically comprises the following steps:
spin-drying and desolventizing the crystallization mother liquor raw material containing b and c to obtain a solid mixture containing a polybrominated substituent c,
mixing the solid mixture with diethyl phosphite and potassium carbonate so that the molar ratio of polybrominated substituent c to potassium carbonate in the solid mixture is 1:3 and the molar ratio of polybrominated substituent c to diethyl phosphite is 1:1.5; after mixing, carrying out reflux reaction for 16 hours in dichloromethane, and washing, drying, desolventizing and crystallizing the reacted product to obtain a monobromo substituent; the reaction process is shown in the following formula (II):
CN202011554293.XA 2020-12-24 2020-12-24 Debromination method of sartan intermediate polybrominated substituent Active CN112441942B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011554293.XA CN112441942B (en) 2020-12-24 2020-12-24 Debromination method of sartan intermediate polybrominated substituent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011554293.XA CN112441942B (en) 2020-12-24 2020-12-24 Debromination method of sartan intermediate polybrominated substituent

Publications (2)

Publication Number Publication Date
CN112441942A CN112441942A (en) 2021-03-05
CN112441942B true CN112441942B (en) 2024-03-26

Family

ID=74740450

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011554293.XA Active CN112441942B (en) 2020-12-24 2020-12-24 Debromination method of sartan intermediate polybrominated substituent

Country Status (1)

Country Link
CN (1) CN112441942B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114478313A (en) * 2021-12-24 2022-05-13 浙江华洲药业有限公司 Method for synthesizing high-purity bromosartanbiphenyl
CN114478315B (en) * 2022-02-25 2023-10-31 山东艾孚特科技有限公司 Method for catalytic reduction of irosartan biphenyl waste residues by using halogen-modified Pd/C catalyst

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103626677A (en) * 2013-12-05 2014-03-12 天津大学 Crystallizing method for preparing high-purity 4-bromomethyl-2-cyanobiphenyl
CN104876836A (en) * 2015-06-12 2015-09-02 山东金城医药化工股份有限公司 Method for utilizing 4-bromomethyl-2-cyanobiphenyl waste residues to prepare 4-bromomethyl-2-cyanobiphenyl
CN108947870A (en) * 2018-07-23 2018-12-07 湖北宇阳药业有限公司 A kind of preparation method of bromo sartanbiphenyl

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103626677A (en) * 2013-12-05 2014-03-12 天津大学 Crystallizing method for preparing high-purity 4-bromomethyl-2-cyanobiphenyl
CN104876836A (en) * 2015-06-12 2015-09-02 山东金城医药化工股份有限公司 Method for utilizing 4-bromomethyl-2-cyanobiphenyl waste residues to prepare 4-bromomethyl-2-cyanobiphenyl
CN108947870A (en) * 2018-07-23 2018-12-07 湖北宇阳药业有限公司 A kind of preparation method of bromo sartanbiphenyl

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Atherton-Todd 反应及其立体化学机理研究进展;曹书霞 等;《中国科学:化学》;第45卷(第3期);283-294页 *

Also Published As

Publication number Publication date
CN112441942A (en) 2021-03-05

Similar Documents

Publication Publication Date Title
CN112441942B (en) Debromination method of sartan intermediate polybrominated substituent
CN111205294A (en) Preparation method of Reidesciclovir intermediate
CN107253912B (en) Synthetic method of cyhalofop-butyl
CN102329277A (en) Method for preparing Parecoxib
CN111233930A (en) Preparation method of Reidesciclovir
CN110305018A (en) A kind of preparation method of the bromo- 2- fluoronitrobenzene of 3-
CN112300102B (en) Synthetic method of furan ammonium salt
KR101595747B1 (en) Method for preparing of nafamostat mesilate
CN106008459B (en) The preparation method of one koji Ge Lieting
CN113372286B (en) Method for preparing 1-phenyl-5-mercapto tetrazole by one-step method
CN111574384B (en) Preparation method of chiral 1-amino-2-propanol
CN107629039B (en) The preparation method and intermediate of deuterated acrylamide
CN105175316A (en) Method for preparing laxative sodium picosulfate
CN106478751B (en) Preparation method of 2',3' -di-O-acetyl-5 ' -deoxy-5-fluoro-N4- [ (pentyloxy) carbonyl ] cytidine
CN108383720A (en) A kind of neighbour's substituted benzoic acid meta position chlorination
CN109574951A (en) A kind of preparation method of Febuxostat
CN111362957B (en) Preparation method of icotinib key intermediate
CN111574540B (en) Preparation method of Degatinib
CN107417622B (en) A refining method of 4(5) -chloro-2-cyano-5 (4) - (4' -methylphenyl) imidazole
CN112979736B (en) Preparation method of Reidesciclovir
CN103130729B (en) Preparation method of 4-chloro-7-methoxyl quinazoline-6-alchol acetate
CN107089928A (en) The synthetic method of N Boc L propargylglycines
JPH08225749A (en) Production of high-purity 3-hydroxy-n-benzimidazolon-5-yl-2-naphthamide necessary for azo pigment
CN116354846A (en) Synthesis process method of pesticide kresoxim-methyl
CN117586167A (en) New synthesis process of chlorfenapyr

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant